K210930 is an FDA 510(k) clearance for the ACUVUE® OASYS MAX 1-DAY Contact Lenses (senofilcon A). Classified as Lenses, Soft Contact, Daily Wear (product code LPL), Class II - Special Controls.
Submitted by Johnson & Johnson Vision Care, Inc. (Jacksonville, US). The FDA issued a Cleared decision on November 29, 2021 after a review of 245 days - an extended review cycle.
This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.5925 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.
View all Johnson & Johnson Vision Care, Inc. devices